VANDETANIB Pharmacologic Class Indexing

Class set ID
910a56fe-3adf-4fd0-b816-d18c04e18234
Version
3
Effective date
20190122
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA ® (vandetanib) tablets, for oral use Initial U.S. Approval: 2011Genzyme Corporation | Lonza AG | Penn Pharmaceutical Services Limited | AstraZeneca Pharmaceuticals LP | HVL Pharma UK Limited2026042314